Sekisui Medical and Sekisui Chemical have sold Sekisui Virotech to Virotech Diagnostics Holdings
Client: Sekisui Medical Co., Ltd, Sekisui Chemical Co., Ltd. (TSE:4204)
Client Location: Japan
Target: Sekisui Virotech GmbH
Target Location: Germany
Buyer: Virotech Diagnostics Holdings GmbH (LEO Familienholding (Sister company of Paragon Partners))
Buyer Location: Germany
Target Description: Sekisui Virotech GmbH develops, manufactures, and markets diagnostic products.
Meet our Senior Team
View More Transactions
Lincoln International is delighted to have represented the shareholders of Ultima Business Solutions Limited on the sale of a majority stake to Apse Capital Limited
Lincoln International Advises Livermore Software Technology Corporation on their announced sale to ANSYS, Inc.
Lincoln International advises Memira, a portfolio company of Patricia Industries, in its sale to Bergman Clinics
Lincoln International is pleased to announce the sale of Nedap France to B & Capital and its management team